Abstract: Poster Presentations |

The Expression of Apoptosis in Cardiac Myxoma FREE TO VIEW

Pao-Hsien Chu, MD*; Shih-Ming Jung, MD
Author and Funding Information

Chang Gung Memorial Hospital and University, Taipei, Taiwan ROC


Chest. 2004;126(4_MeetingAbstracts):788S. doi:10.1378/chest.126.4_MeetingAbstracts.788S-a
Text Size: A A A
Published online


PURPOSE:  Cardiac myxoma, the most common primary tumor of the heart, has a variable clinical presentation. It has been proposed that apoptosis (programmed cell death) is critical in several cardiovascular diseases but not cardiac myxoma. This study was designed to identify and characterize apoptosis in cardiac myxoma.

METHODS:  A retrospective study was conducted between December 1976 and June, 2003, including 103 consecutive patients with cardiac myxoma whose tumors had been surgically excised. Apoptosis was studied using TUNEL and DNA fragmentation assays and by immunochemical studies for activation of caspase-3 and TNFα] in tumor tissue. We analyzed samples from 32 randomly selected cardiac myxoma patients.

RESULTS:  Of the 103 myxoma patients, 58 were women, 45 men (age 39 ± 21 y). Clinical presentations included asymptomatic (41%), dyspnea (33%), stroke (22%), chest pain (7%), fever (6%), syncope (5%) and tricuspid regurgitation (72%). Ninety-two myxomas were in left atrium, four recurrent myxomas and eight other myxomas were located elsewhere. These Myxomas did not differ in terms of pathological scores including vascular proliferation, inflammation, cellularity, hyaline, calcification and thrombosis. Most (85%) were characterized by extensive apoptosis but none involved activation of caspase-3.

CONCLUSION:  Apoptosis is very common in myxomas but does not involve caspase-3. Our results indicate that apoptosis has a novel pathological pattern in cardiac myxomas, a pattern that does not include activation of the caspase-3 pathway. These findings should help identify and characterize any possible role for apoptosis in the development of cardiac myxoma.

CLINICAL IMPLICATIONS:  The clinical implications of apoptosis in cardiac myxoma require further evaluation, this finding creates the possibility of treatments based on monoclonal antibodies or vaccination strategies, like those that already have been established for other tumor entities.

DISCLOSURE:  P. Chu, None.

Wednesday, October 27, 2004

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543